An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of ...

A study on over 800k adults with type 2 diabetes found that semaglutide and other GLP-1 drugs did not increase or decrease ...

Understanding complex rheumatological conditions requires both medical expertise and compassion. In this exclusive interview, Dr. Aruna Caldera, Consultant Rheumatologist, speaks with Zanita Careem ...

Millions of people with type 2 diabetes who take semaglutide, the active ingredient in Ozempic and Wegovy, can draw some ...

Although advances in DMARDs have improved outcomes, some people with axSpA experience an inadequate response to therapy.

Scientists have uncovered evidence that serotonin, the chemical best known for regulating mood, may also speed the ...

Commonwealth Games-bound Derbyshire boxer Chantelle Reid reflects on how a degenerative back problem delayed her career and ...

Results point to potential to restore vision with drugs, non-invasively, reversibly, via a mechanism that is independent to ...

Shaun McKenna was diagnosed with the degenerative condition Huntington's Disease in 2022.

After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden reduction through 2 years 4D-150 continues to be well ...

Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the successful manufacture of the first ...

A talent and a team player, Nick Lowden excelled at Aussie Rules. But the knocks, bumps, hits and collisions were adding up.